TENAX THERAPEUTICS, INC. (TENX) [Rocket]

In millions, except per share items	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Apr-30-15	Apr-30-14
	10-K	10-K	10-K/A	10-K	10-K	10-K	10-K	10-K
Total revenues [+]	65.5	19.7	17.1	13.8	18.4	105.3	0.0	0.2
Products								0.0
Revenue growth	231.7%	15.3%	24.1%	-25.1%	-82.5%		-69.0%	-86.7%
Cost of goods sold	0.0	0.0	0.0	0.0	0.0	0.0	-29.6	0.1
Gross profit	65.5	19.7	17.1	13.8	18.4	105.3	29.7	0.0
Gross margin	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	60225.6%	18.3%
Selling, general and administrative	7.6	5.3	5.1	5.7	5.7	6.2	7.2	13.8
Research and development	25.1	4.6	3.5	1.2	3.5	13.1	6.7	3.0
Other operating expenses								-33.4
EBITDA [+]	32.7	9.9	8.6	6.9	9.2	85.9	16.0	16.8
EBITDA growth	231.6%	15.3%	24.0%	-25.1%	-89.3%		-4.5%	200.1%
EBITDA margin	50.0%	50.0%	50.0%	50.1%	50.1%	81.6%	32463.1%	10546.8%
Depreciation	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1
EBITA	32.7	9.9	8.6	6.9	9.2	85.9	15.9	16.7
EBITA margin	50.0%	50.0%	50.0%	50.0%	50.0%	81.6%	32305.1%	10491.2%
Amortization of intangibles							0.1	0.1
EBIT [+]	32.7	9.9	8.6	6.9	9.2	85.9	15.9	16.6
EBIT growth	231.7%	15.3%	24.1%	-25.1%	-89.3%		-4.6%	205.5%
EBIT margin	50.0%	50.0%	50.0%	50.0%	50.0%	81.6%	32162.5%	10452.1%
Non-recurring items [+]						33.3	1.0
Asset impairment						33.3	1.0
Interest expense, net [+]	0.0	0.0					0.0	2.2
Interest expense							0.0	2.2
Interest income	0.0	0.0
Other income (expense), net [+]	-65.2	-19.7	-0.2	7.3	-0.4	-16.7	-0.7	5.1
Unrealized gain (loss) on marketable securities	0.0	0.0	0.0	0.0	0.0	-0.1	0.0
Other			-0.2	-0.1	-0.4	-0.8	0.8	-0.7
Pre-tax income	-32.5	-9.9	8.4	14.1	8.8	36.0	14.1	19.5
Income taxes	0.0	0.0	0.0	0.0	0.0	-8.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%		0.0%	0.0%
Net income	-32.5	-9.9	8.4	14.1	8.8	43.9	14.1	25.3
Net margin	-49.6%	-49.9%	49.1%	102.6%	48.0%	41.7%	28571.6%	15947.8%

Basic EPS [+]	($1.58)	($0.95)	$1.35	$9.04	$6.27	$31.24	$0.50	$2.71
Growth	66.1%	-170.1%	-85.0%	44.2%	-79.9%		-81.5%	-56.9%
Diluted EPS [+]	($1.58)	($0.95)	$1.35	$9.04	$6.27	$31.24	$0.50	$2.71
Growth	66.1%	-170.1%	-85.0%	44.2%	-79.9%		-81.5%	-54.1%

Shares outstanding (basic) [+]	20.6	10.4	6.2	1.6	1.4	1.4	28.1	9.4
Growth	98.5%	67.3%	295.9%	10.9%	0.3%		199.9%	467.3%
Shares outstanding (diluted) [+]	20.6	10.4	6.2	1.6	1.4	1.4	28.1	9.4
Growth	98.5%	67.3%	295.9%	10.9%	0.3%		199.9%	432.2%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.